ACEA Biosciences, Inc. (ACEA) is a privately owned biotechnology company pioneering in the development and commercialization of high-performance, cutting edge research instrumentation for life sciences. ACEA's mission is to transform cell analysis by providing innovative products and solutions to the research and drug discovery community. Today, the company has a product line of eight instruments which utilize this technology with different functionalities and throughputs, and enables different types of cell-based applications. ACEA's xCELLigence® impedance-based, label-free, real time cell analysis system and NovoCyte™ flow cytometers are used in pre-clinical drug discovery and development, toxicity, safety pharmacology, and basic academic research. The application range is broad and diverse.
NovoCyte, a New High Performance Flow Cytometer for Everyone
Exceptional Performance at a Low Investment Cost
ACEA offers a system which is:
Powerful- up to 15 parameter detection with enhanced sensitivity and resolution.
Intuitive - automated instrument maintenance functions and advanced data analysis capabilities for greater usability.
Customizable - 1 to 3 laser options, exchangeable filters, multiple sampling options and flexible analysis formats.
Other important features enhance usability such as a fixed optical alignment, 24-bit detection dynamic range with no need for PMT voltage adjustment, accurate volumetric-based cell counting, pressure sensors to monitor fluidic status in real-time, and automatic cleaning and de-contamination processes.
Label Free technology in Cancer research
Acea Biosciences brings in an innovative technology for Real Time Kinetic Measurements.
Labelling can in some cases either block the active site of target proteins or lead to significant changes in conformation of the protein that affects its function. Label-free assays overcome these deficiencies, reduce assay time and expedite workflow.